Boston Scientific's EBITDA per Share for the
three
months ended in Dec. 2023 was $0.60.
During the past 12 months, Boston Scientific's average EBITDA Per Share Growth Rate was 23.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 33.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 7.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 19.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Boston Scientific was 83.10% per year. The lowest was -271.10% per year. And the median was 17.75% per year.
Competitive Comparison
For the Medical Devices subindustry, Boston Scientific's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific 5-Year EBITDA Growth Rate Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Boston Scientific's 5-Year EBITDA Growth Rate falls into.
Boston Scientific 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
Boston Scientific (NYSE:BSX) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Boston Scientific 5-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of Boston Scientific's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Boston Scientific (Boston Scientific) Business Description
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSX has been successfully added to your